LICENSE AGREEMENT WITH INSERM (Details Narrative) |
Feb. 11, 2021
USD ($)
|
|---|---|
| Inserm License Agreement [Member] | Inserm [Member] | Oxytocin-based Therapeutics [Member] | |
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |
| Sales milestones | $ 400,000 |
| X | ||||||||||
- Definition Sales milestones specified in license agreement. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|